| |
|
|
|
Infinity Pharmaceuti  
|
|
2.03 -0.015 (-0.01%) |
05-25 16:00 |
|
Open: |
2.06 |
Pre close: |
2.045 |
Target:
|
2.53
|
|
High: |
2.06 |
Low: |
1.99 |
Resistance:
|
2.17
2.32
|
|
Volume: |
288,858 |
Market Cap: |
114M |
Support:
|
1.92
1.60
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.02
 |
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
2.08  |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
2.13 |
Stochastic Oscillator |
%K(14,3):
|
36.46 |
|
MA(250): |
1.86 |
%D(3): |
33.33 |
|
Average Volume(K) |
3-Month: |
72484
|
52-Week |
High:
|
3.75 |
|
10-Days: |
37507 |
Low: |
0.93 |
|
RSI |
RSI(14):
|
44.74 |
Change(%): |
18.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.800 |
Return on Equity (ttm) |
-68.5 |
Shares Out. (M) |
56.07 |
|
EPS Est. Current Year |
-0.920 |
Return on Assets (ttm) |
-53.1 |
Shares Float (M) |
53.29 |
|
EPS Est. Next Year |
-1.500 |
PEG Ratio |
-0.03 |
% Held by Insiders |
5.40 |
|
EPS Est. Next Quarter |
-0.200 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
49.20 |
|
Forward EPS |
-0.590 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1938 |
|
Book Value (p.s.) |
2.520 |
EBITDA (p.s.) |
-0.402 |
P/E |
-2.54 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.81 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.79 |
P/S |
948517504.00 |
|
Operating Margin |
-591.43 |
Levered Free Cash Flow
(M) |
-17.07 |
P/CF |
-3.95 |
|
|
|
|
|
|
